Granules India Limited
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally. It offers paracetamol, metformin, guaifenesin, and methocarbamol, as well as prescription and over-the-counter products. The company also develops and manufactures tablets, capsules, press fits, oral solutions, s… Read more
Market Cap & Net Worth: Granules India Limited (GRANULES)
Granules India Limited (NSE:GRANULES) has a market capitalization of $1.64 Billion (₹142.39 Billion) as of March 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #7461 globally and #283 in its home market, demonstrating a 5.84% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Granules India Limited's stock price ₹586.75 by its total outstanding shares 242668716 (242.67 Million).
Granules India Limited Market Cap History: 2015 to 2026
Granules India Limited's market capitalization history from 2015 to 2026. Data shows growth from $395.08 Million to $1.64 Billion (14.30% CAGR).
Index Memberships
Granules India Limited is a constituent of 6 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY PHARMA
CNXPHARMA
|
$58.09 Billion | 1.66% | #16 of 20 |
|
NIFTY 500
NIFTY500
|
$1.33 Trillion | 0.07% | #255 of 500 |
|
NIFTY HEALTHCARE
NIFTYHEALTHCARE
|
$72.50 Billion | 1.33% | #16 of 20 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$535.62 Billion | 0.18% | #170 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$1.39 Trillion | 0.07% | #255 of 750 |
|
NIFTY SMALLCAP 250
NISM250
|
$188.43 Billion | 0.51% | #56 of 250 |
Weight: Granules India Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Granules India Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Granules India Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.04x
Granules India Limited's market cap is 0.04 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.33x
Granules India Limited's market cap is 0.33 times its annual earnings
10.29x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $288.61 Million | $13.57 Billion | $1.23 Billion | 0.02x | 0.23x |
| 2017 | $370.70 Million | $14.11 Billion | $1.65 Billion | 0.03x | 0.23x |
| 2018 | $244.28 Million | $16.85 Billion | $1.33 Billion | 0.01x | 0.18x |
| 2019 | $338.49 Million | $22.79 Billion | $2.36 Billion | 0.01x | 0.14x |
| 2020 | $972.16 Million | $25.99 Billion | $3.35 Billion | 0.04x | 0.29x |
| 2021 | $932.08 Million | $32.38 Billion | $5.49 Billion | 0.03x | 0.17x |
| 2022 | $886.71 Million | $37.65 Billion | $4.13 Billion | 0.02x | 0.21x |
| 2023 | $1.13 Billion | $45.12 Billion | $5.17 Billion | 0.03x | 0.22x |
| 2024 | $1.66 Billion | $45.06 Billion | $4.05 Billion | 0.04x | 0.41x |
| 2025 | $1.68 Billion | $44.82 Billion | $5.02 Billion | 0.04x | 0.33x |
Competitor Companies of GRANULES by Market Capitalization
Companies near Granules India Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Granules India Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Granules India Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Granules India Limited's market cap moved from $395.08 Million to $ 1.64 Billion, with a yearly change of 14.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹1.64 Billion | -1.96% |
| 2025 | ₹1.68 Billion | +1.05% |
| 2024 | ₹1.66 Billion | +46.47% |
| 2023 | ₹1.13 Billion | +27.78% |
| 2022 | ₹886.71 Million | -4.87% |
| 2021 | ₹932.08 Million | -4.12% |
| 2020 | ₹972.16 Million | +187.20% |
| 2019 | ₹338.49 Million | +38.57% |
| 2018 | ₹244.28 Million | -34.10% |
| 2017 | ₹370.70 Million | +28.45% |
| 2016 | ₹288.61 Million | -26.95% |
| 2015 | ₹395.08 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Granules India Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.64 Billion USD |
| MoneyControl | $1.64 Billion USD |
| MarketWatch | $1.64 Billion USD |
| marketcap.company | $1.64 Billion USD |
| Reuters | $1.64 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.